Nuvation Bio appoints Moses Makunje as Principal Accounting Officer and Principal Financial Officer

Nuvation Bio Inc.

Appointment effective Nov 27, 2023; Makunje previously VP Finance since Jan 2022.
Annual base salary of $343,873; eligible for discretionary incentive bonus with 35% target.
CPA with over 16 years experience including at Ernst & Young and Maze Therapeutics.
No family relationships with directors or other officers; no material transactions disclosed.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Moses Makunje

Principal Accounting Officer and Principal Financial Officer

NUVB · Nuvation Bio Inc.

Effective: 2023-11-27
Filed: November 27, 2023, 6:59 PM ET

Effective November 27, 2023, the Board of Nuvation Bio Inc. (the “Company”) appointed Moses Makunje as the Company’s Principal Accounting Officer and Principal Financial Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Moses Makunje was appointed as Principal Accounting Officer and Principal Financial Officer at Nuvation Bio Inc..

Action: appointed
Role: Principal Accounting Officer and Principal Financial Officer

Exact text from the filing

Effective November 27, 2023, the Board of Nuvation Bio Inc. (the “Company”) appointed Moses Makunje as the Company’s Principal Accounting Officer and Principal Financial Officer.

View on SEC.gov

Nuvation Bio Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-283346

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.